Elicio Therapeutics (ELTX)
NASDAQ:ELTX
Holding ELTX?
Track your performance easily

Elicio Therapeutics (ELTX) Financial Statements

195 Followers

Elicio Therapeutics Financial Overview

Elicio Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.996; its P/E ratio is -1.27; Elicio Therapeutics is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.23M$ -11.21M$ -10.66M$ -7.56M$ -7.69M
EBITDA$ -6.95M$ -10.90M$ -10.39M$ -7.05M$ -7.59M
Net Income Common Stockholders$ -7.23M$ -11.83M$ -10.66M$ -7.56M$ -8.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.40M$ 11.90M$ 14.84M$ 21.68M$ 29.20M
Total Assets$ 15.75M$ 24.48M$ 30.99M$ 37.62M$ 41.77M
Total Debt$ 6.42M$ 6.67M$ 7.15M$ 7.40M$ 297.00K
Net Debt$ 3.02M$ -5.23M$ -7.69M$ -14.28M$ -28.90M
Total Liabilities$ 17.40M$ 19.61M$ 17.70M$ 14.06M$ 2.10M
Stockholders Equity$ -1.65M$ 4.87M$ 13.29M$ 23.56M$ 39.67M
Cash Flow-
Free Cash Flow$ -8.97M$ -12.12M$ -5.23M$ -9.45M$ -8.16M
Operating Cash Flow$ -8.93M$ -12.12M$ -5.18M$ -9.47M$ -8.14M
Investing Cash Flow$ -42.00K$ 3.00K$ -45.00K$ 30.00K$ -17.00K
Financing Cash Flow$ 316.00K$ 11.02M$ 59.00K$ 21.51M$ 10.04M
Currency in USD

Elicio Therapeutics Earnings and Revenue History

Elicio Therapeutics Debt to Assets

Elicio Therapeutics Cash Flow

Elicio Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis